Is it safe for a patient with hypertension and bipolar disorder to take nebivolol (beta-blocker) 2.5mg with lithium (mood stabilizer) 1mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Nebivolol 2.5mg with Lithium 1mg

Yes, it is safe to take nebivolol 2.5mg with lithium, as beta-blockers do not have clinically significant interactions with lithium and nebivolol is not metabolized or eliminated through pathways that affect lithium levels. 1

Key Safety Considerations

No Direct Drug-Drug Interaction

  • Nebivolol has been studied extensively for drug-drug interactions and shows no significant interactions with commonly co-administered cardiovascular medications. 1
  • Beta-blockers are not listed among the drug classes that increase lithium toxicity risk, unlike ACE inhibitors, ARBs, and thiazide diuretics. 2, 3
  • The 2020 International Society of Hypertension guidelines specifically recommend beta-blockers (excluding metoprolol) for patients with psychiatric diseases and hypertension, acknowledging their safety in this population. 4

Lithium-Sparing Antihypertensive Choice

  • For patients on lithium requiring blood pressure control, RAS inhibitors (ACE inhibitors/ARBs) and diuretics pose the highest risk of lithium toxicity and should be avoided or used with extreme caution. 4, 2, 3
  • Case reports document severe lithium intoxication (levels >3.0 mEq/L) occurring within weeks to months of starting ACE inhibitors or ARBs in previously stable patients. 2, 3
  • Nebivolol, as a beta-blocker, does not affect renal lithium clearance and represents a safer antihypertensive option. 1

Nebivolol-Specific Advantages in This Population

Metabolic and Psychiatric Benefits

  • Nebivolol has superior metabolic effects compared to traditional beta-blockers, with no adverse impact on glucose tolerance or insulin sensitivity. 5
  • Unlike traditional beta-blockers, nebivolol does not cause sexual dysfunction or decreased libido, which is particularly important in patients already managing psychiatric medication side effects. 6
  • The nitric oxide-mediated vasodilatory properties of nebivolol provide effective blood pressure reduction without the fatigue commonly associated with traditional beta-blockers. 7

Appropriate Dosing

  • The 2.5mg dose of nebivolol is a reasonable starting dose, with the standard therapeutic dose being 5mg once daily. 6
  • This allows for gradual titration based on blood pressure response and tolerability. 6

Critical Monitoring Requirements

Lithium Level Surveillance

  • Even though nebivolol does not interact with lithium, continue routine lithium level monitoring (every 3-6 months in stable patients) as lithium has a narrow therapeutic window (0.6-1.2 mEq/L). 2, 3
  • Monitor for signs of lithium toxicity: tremor, confusion, ataxia, diarrhea, or altered mental status. 2, 3

Blood Pressure and Heart Rate Monitoring

  • Target blood pressure <130/80 mmHg in patients with hypertension and psychiatric comorbidities. 4
  • Monitor for symptomatic bradycardia or hypotension, though nebivolol has lower rates of bradycardia compared to other beta-blockers. 7

Important Caveats

Renal Function Consideration

  • Both lithium and nebivolol require adequate renal function for elimination. 2, 3
  • Monitor serum creatinine and estimated glomerular filtration rate, particularly if adding other medications or if the patient develops dehydration or acute illness. 2, 3

Drug Interactions to Avoid

  • Never combine lithium with ACE inhibitors, ARBs, or thiazide diuretics without intensive monitoring, as these dramatically increase lithium toxicity risk. 2, 3
  • NSAIDs should also be avoided or used cautiously as they can increase lithium levels. 2

CYP2D6 Metabolism

  • Nebivolol is metabolized by CYP2D6, but this does not affect lithium levels. 1
  • If the patient is taking fluoxetine or other CYP2D6 inhibitors, nebivolol clearance may be reduced, requiring dose adjustment of nebivolol (not lithium). 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.